Searched for
PFIZER ACQUISITION
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
- Pfizer acquires AstraZeneca's Neksium for Rs 75 croreNeksium was launched in India in the year 2006 and has developed strong equity with prescribers as a leading, high quality product in the A...
- Pfizer surges 5% as parent acquires Medivation in $14 bn dealThe US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.
- Pfizer, allergan in talks to forge $330bn giant: WSJA bid for Allergan would be Pfizer's second attempt to acquire a European rival, following its unsuccessfully courtship of AstraZeneca Plc.
- Pfizer shares gain over 3% as parent plans to buy HospiraShares of Pfizer rose by over 3 per cent as pharmaceuticals giant Pfizer Inc will acquire Hospira Inc, a leading provider of injectable dru...
- Pfizer buying Hospira for about $15.23 billionPfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.
- Drug firm Pfizer gets Bombay High Court nod for merger of Wyeth LtdIn November last year Pfizer and Wyeth had said they will merge their India operations under a single brand as part of efforts to boost bus...
- Pfizer, AstraZeneca shares climb up amidst deal talksThe two drugmakers declined to confirm the development, even as the news sent market punters to bet on the likely impact on its Indian subs...
- Pfizer, Wyeth board meet on Nov 23 to discuss merger plansPfizer India today said the respective Boards of Directors of Pfizer Ltd and Wyeth Ltd will meet on November 23 to consider the merger prop...
- CCI gives nod to Nestle-Pfizer acquisitionThe competition regulator has given the green signal to the proposed acquisition of the nutrition business of Pfizer by the FMCG major, Nes...
- Pfizer buys into Brazilian drug maker TeutoUS pharmaceutical giant Pfizer said Wednesday it has bought 40 percent of Brazilian drug company Teuto for 238 million dollars as part of i...
- Pfizer to continue recruitment drivePfizer India will hire an additional 200 people in the next few months and will continue to increase its headcount because it sees minimal ...
- Prabhudas Lilladher retains 'accumulate' on PfizerPrabhudas Lilladher has retained its ‘accumulate’ rating on Pfizer with a price target of Rs 652
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
- Reports: Pfizer, Wyeth said to be close to dealPfizer and Wyeth are closing in on a deal worth $68 billion that could be announced before the markets open Monday.
- J&J takes over Pfizer’s OTC unitThe acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...
Load More
